Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.040
-0.020 (-1.89%)
At close: Dec 8, 2025, 4:00 PM EST
1.054
+0.014 (1.31%)
After-hours: Dec 8, 2025, 7:27 PM EST
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $6.56 million as of December 8, 2025. Its market cap has decreased by -60.01% in one year.
Market Cap
6.56M
Enterprise Value
-7.03M
1-Year Change
-60.01%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $6.56M, a decrease of -65.34%. That is a compound annual growth rate of -25.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 6.69M | -62.59% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |